Record #20310
Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Notes from Retraction Watch
see also: https://pubpeer.com/publications/ECAE674D2B96F98DF26BDC250EA222;
Citation lifecycle
How this paper is being cited
Pre-retraction
25
Same day
1
Post-retraction
13
% post-retraction
33.3%
~3.4 citations/yr before retraction · ~1.7 citations/yr after
— citing papers
Who is still citing this work
Loading…